| __timestamp | Celldex Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 4320000 |
| Thursday, January 1, 2015 | 5480000 | 2538000 |
| Friday, January 1, 2016 | 6786000 | 3337000 |
| Sunday, January 1, 2017 | 12743000 | 4003000 |
| Monday, January 1, 2018 | 9538000 | 8386000 |
| Tuesday, January 1, 2019 | 3573000 | 4461000 |
| Wednesday, January 1, 2020 | 7418000 | 1050000 |
| Friday, January 1, 2021 | 4651000 | 2963000 |
| Saturday, January 1, 2022 | 2357000 | 1772000 |
| Sunday, January 1, 2023 | 6883000 | 314000 |
Cracking the code
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. have showcased contrasting revenue trajectories. Celldex experienced a remarkable peak in 2017, with revenues soaring to nearly double their 2014 figures. However, by 2022, their revenue had dipped by approximately 82%, highlighting the volatile nature of the biotech sector. In contrast, Viridian's revenue journey has been more erratic, with a significant spike in 2018, followed by a sharp decline to just 9% of their peak by 2023. This comparison underscores the challenges and opportunities within the biotech industry, where innovation and market dynamics can lead to rapid shifts in financial performance.
Revenue Showdown: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Zoetis Inc. vs Celldex Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Showdown: argenx SE vs Viridian Therapeutics, Inc.
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Viridian Therapeutics, Inc.
Annual Revenue Comparison: BeiGene, Ltd. vs Viridian Therapeutics, Inc.
Exelixis, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Grifols, S.A. and Celldex Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: TG Therapeutics, Inc. or Viridian Therapeutics, Inc.?
Revenue Showdown: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Revenue Showdown: Mesoblast Limited vs Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.